Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial

Abstract To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization days over 5 years with data from the site-randomized RAI...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Schizophrenia bulletin 2022-09, Vol.48 (5), p.1021-1031
Hauptverfasser: Robinson, Delbert G, Schooler, Nina R, Marcy, Patricia, Gibbons, Robert D, Hendricks Brown, C, John, Majnu, Mueser, Kim T, Penn, David L, Rosenheck, Robert A, Addington, Jean, Brunette, Mary F, Correll, Christoph U, Estroff, Sue E, Mayer-Kalos, Piper S, Gottlieb, Jennifer D, Glynn, Shirley M, Lynde, David W, Gingerich, Susan, Pipes, Ronny, Miller, Alexander L, Severe, Joanne B, Kane, John M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1031
container_issue 5
container_start_page 1021
container_title Schizophrenia bulletin
container_volume 48
creator Robinson, Delbert G
Schooler, Nina R
Marcy, Patricia
Gibbons, Robert D
Hendricks Brown, C
John, Majnu
Mueser, Kim T
Penn, David L
Rosenheck, Robert A
Addington, Jean
Brunette, Mary F
Correll, Christoph U
Estroff, Sue E
Mayer-Kalos, Piper S
Gottlieb, Jennifer D
Glynn, Shirley M
Lynde, David W
Gingerich, Susan
Pipes, Ronny
Miller, Alexander L
Severe, Joanne B
Kane, John M
description Abstract To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization days over 5 years with data from the site-randomized RAISE-ETP trial that compared the EIS NAVIGATE (17 sites; 223 participants) and community care (CC) (17 sites; 181 participants). Inclusion criteria were: age 15–40 years; DSM-IV diagnoses of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, or psychotic disorder not otherwise specified; first psychotic episode; antipsychotic medication taken for ≤6 months. NAVIGATE-randomized participants could receive NAVIGATE from their study entry date until NAVIGATE ended when the last-enrolled NAVIGATE participant completed 2 years of treatment. Assessments occurred every 6 months. 61% of participants had assessments conducted ≥2 years; 31% at 5 years. Median follow-up length was CC 30 months and NAVIGATE 38 months. Primary analyses assumed data were not-missing-at-random (NMAR); sensitivity analyses assumed data were missing-at-random (MAR). MAR analyses found no significant treatment-by-time interactions for QLS or PANSS. NMAR analyses revealed that NAVIGATE was associated with a 13.14 (95%CI:6.92,19.37) unit QLS and 7.73 (95%CI:2.98,12.47) unit PANSS better improvement and 2.53 (95%CI:0.59,4.47) fewer inpatient days than CC (all comparisons significant). QLS and PANSS effect sizes were 0.856 and 0.70. NAVIGATE opportunity length (mean 33.8 (SD = 5.1) months) was not associated (P = .72) with QLS outcome; duration of untreated psychosis did not moderate (P = .32) differential QLS outcome. While conclusions are limited by the low rate of five-year follow-up, the data support long-term benefit of NAVIGATE compared to community care.
doi_str_mv 10.1093/schbul/sbac053
format Article
fullrecord <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9434430</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/schbul/sbac053</oup_id><sourcerecordid>10.1093/schbul/sbac053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-46201785a8dddc6b1a486afb198c572004c6ee02a7c21f330db26ba8b18a96c43</originalsourceid><addsrcrecordid>eNqFkcFPwjAUxhujEUSvHk2vHgbt1nWdBxOCQ0lIIIAHT0vXdVCzraTdSPCv8E-2BiR68vS-5H3f7-XlA-AWoz5GcTCwYpO15cBmXKAwOANdHJHQwxHC56CLQka9iGLSAVfWviOESUz9S9AJQspiErEu-Jy1jdCVtPCpNapeQ17ncFg00sCEm3IPJ7XTO1k3Stdw6aQSzlxoA8fK2MZLtsrqXMK53YuNtso-wIW0bdlYONs5SgjfJDcWjo2uYLORcDGcLBMvWc3hUjXSW7iDulIfMocro3h5DS4KXlp5c5w98DpOVqMXbzp7noyGU08QnzQeoT7CEQs5y_Nc0AxzwigvMhwzEUY-QkRQKZHPI-HjIghQnvk04yzDjMdUkKAHHg_cbZtVMhfuQ8PLdGtUxc0-1Vylfze12qRrvUtjEhASIAfoHwDCaGuNLE5ZjNLvbtJDN-mxGxe4-33xZP8pwxnuDwbdbv-DfQGPxJ3w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Robinson, Delbert G ; Schooler, Nina R ; Marcy, Patricia ; Gibbons, Robert D ; Hendricks Brown, C ; John, Majnu ; Mueser, Kim T ; Penn, David L ; Rosenheck, Robert A ; Addington, Jean ; Brunette, Mary F ; Correll, Christoph U ; Estroff, Sue E ; Mayer-Kalos, Piper S ; Gottlieb, Jennifer D ; Glynn, Shirley M ; Lynde, David W ; Gingerich, Susan ; Pipes, Ronny ; Miller, Alexander L ; Severe, Joanne B ; Kane, John M</creator><creatorcontrib>Robinson, Delbert G ; Schooler, Nina R ; Marcy, Patricia ; Gibbons, Robert D ; Hendricks Brown, C ; John, Majnu ; Mueser, Kim T ; Penn, David L ; Rosenheck, Robert A ; Addington, Jean ; Brunette, Mary F ; Correll, Christoph U ; Estroff, Sue E ; Mayer-Kalos, Piper S ; Gottlieb, Jennifer D ; Glynn, Shirley M ; Lynde, David W ; Gingerich, Susan ; Pipes, Ronny ; Miller, Alexander L ; Severe, Joanne B ; Kane, John M</creatorcontrib><description>Abstract To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization days over 5 years with data from the site-randomized RAISE-ETP trial that compared the EIS NAVIGATE (17 sites; 223 participants) and community care (CC) (17 sites; 181 participants). Inclusion criteria were: age 15–40 years; DSM-IV diagnoses of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, or psychotic disorder not otherwise specified; first psychotic episode; antipsychotic medication taken for ≤6 months. NAVIGATE-randomized participants could receive NAVIGATE from their study entry date until NAVIGATE ended when the last-enrolled NAVIGATE participant completed 2 years of treatment. Assessments occurred every 6 months. 61% of participants had assessments conducted ≥2 years; 31% at 5 years. Median follow-up length was CC 30 months and NAVIGATE 38 months. Primary analyses assumed data were not-missing-at-random (NMAR); sensitivity analyses assumed data were missing-at-random (MAR). MAR analyses found no significant treatment-by-time interactions for QLS or PANSS. NMAR analyses revealed that NAVIGATE was associated with a 13.14 (95%CI:6.92,19.37) unit QLS and 7.73 (95%CI:2.98,12.47) unit PANSS better improvement and 2.53 (95%CI:0.59,4.47) fewer inpatient days than CC (all comparisons significant). QLS and PANSS effect sizes were 0.856 and 0.70. NAVIGATE opportunity length (mean 33.8 (SD = 5.1) months) was not associated (P = .72) with QLS outcome; duration of untreated psychosis did not moderate (P = .32) differential QLS outcome. While conclusions are limited by the low rate of five-year follow-up, the data support long-term benefit of NAVIGATE compared to community care.</description><identifier>ISSN: 0586-7614</identifier><identifier>EISSN: 1745-1701</identifier><identifier>DOI: 10.1093/schbul/sbac053</identifier><identifier>PMID: 35689478</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Adolescent ; Adult ; Antipsychotic Agents - therapeutic use ; Diagnostic and Statistical Manual of Mental Disorders ; Humans ; Psychotic Disorders - diagnosis ; Quality of Life ; Regular ; Schizophrenia - drug therapy ; Young Adult</subject><ispartof>Schizophrenia bulletin, 2022-09, Vol.48 (5), p.1021-1031</ispartof><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com 2022</rights><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-46201785a8dddc6b1a486afb198c572004c6ee02a7c21f330db26ba8b18a96c43</citedby><cites>FETCH-LOGICAL-c424t-46201785a8dddc6b1a486afb198c572004c6ee02a7c21f330db26ba8b18a96c43</cites><orcidid>0000-0001-6606-4507</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434430/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434430/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1578,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35689478$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Robinson, Delbert G</creatorcontrib><creatorcontrib>Schooler, Nina R</creatorcontrib><creatorcontrib>Marcy, Patricia</creatorcontrib><creatorcontrib>Gibbons, Robert D</creatorcontrib><creatorcontrib>Hendricks Brown, C</creatorcontrib><creatorcontrib>John, Majnu</creatorcontrib><creatorcontrib>Mueser, Kim T</creatorcontrib><creatorcontrib>Penn, David L</creatorcontrib><creatorcontrib>Rosenheck, Robert A</creatorcontrib><creatorcontrib>Addington, Jean</creatorcontrib><creatorcontrib>Brunette, Mary F</creatorcontrib><creatorcontrib>Correll, Christoph U</creatorcontrib><creatorcontrib>Estroff, Sue E</creatorcontrib><creatorcontrib>Mayer-Kalos, Piper S</creatorcontrib><creatorcontrib>Gottlieb, Jennifer D</creatorcontrib><creatorcontrib>Glynn, Shirley M</creatorcontrib><creatorcontrib>Lynde, David W</creatorcontrib><creatorcontrib>Gingerich, Susan</creatorcontrib><creatorcontrib>Pipes, Ronny</creatorcontrib><creatorcontrib>Miller, Alexander L</creatorcontrib><creatorcontrib>Severe, Joanne B</creatorcontrib><creatorcontrib>Kane, John M</creatorcontrib><title>Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial</title><title>Schizophrenia bulletin</title><addtitle>Schizophr Bull</addtitle><description>Abstract To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization days over 5 years with data from the site-randomized RAISE-ETP trial that compared the EIS NAVIGATE (17 sites; 223 participants) and community care (CC) (17 sites; 181 participants). Inclusion criteria were: age 15–40 years; DSM-IV diagnoses of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, or psychotic disorder not otherwise specified; first psychotic episode; antipsychotic medication taken for ≤6 months. NAVIGATE-randomized participants could receive NAVIGATE from their study entry date until NAVIGATE ended when the last-enrolled NAVIGATE participant completed 2 years of treatment. Assessments occurred every 6 months. 61% of participants had assessments conducted ≥2 years; 31% at 5 years. Median follow-up length was CC 30 months and NAVIGATE 38 months. Primary analyses assumed data were not-missing-at-random (NMAR); sensitivity analyses assumed data were missing-at-random (MAR). MAR analyses found no significant treatment-by-time interactions for QLS or PANSS. NMAR analyses revealed that NAVIGATE was associated with a 13.14 (95%CI:6.92,19.37) unit QLS and 7.73 (95%CI:2.98,12.47) unit PANSS better improvement and 2.53 (95%CI:0.59,4.47) fewer inpatient days than CC (all comparisons significant). QLS and PANSS effect sizes were 0.856 and 0.70. NAVIGATE opportunity length (mean 33.8 (SD = 5.1) months) was not associated (P = .72) with QLS outcome; duration of untreated psychosis did not moderate (P = .32) differential QLS outcome. While conclusions are limited by the low rate of five-year follow-up, the data support long-term benefit of NAVIGATE compared to community care.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Diagnostic and Statistical Manual of Mental Disorders</subject><subject>Humans</subject><subject>Psychotic Disorders - diagnosis</subject><subject>Quality of Life</subject><subject>Regular</subject><subject>Schizophrenia - drug therapy</subject><subject>Young Adult</subject><issn>0586-7614</issn><issn>1745-1701</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFPwjAUxhujEUSvHk2vHgbt1nWdBxOCQ0lIIIAHT0vXdVCzraTdSPCv8E-2BiR68vS-5H3f7-XlA-AWoz5GcTCwYpO15cBmXKAwOANdHJHQwxHC56CLQka9iGLSAVfWviOESUz9S9AJQspiErEu-Jy1jdCVtPCpNapeQ17ncFg00sCEm3IPJ7XTO1k3Stdw6aQSzlxoA8fK2MZLtsrqXMK53YuNtso-wIW0bdlYONs5SgjfJDcWjo2uYLORcDGcLBMvWc3hUjXSW7iDulIfMocro3h5DS4KXlp5c5w98DpOVqMXbzp7noyGU08QnzQeoT7CEQs5y_Nc0AxzwigvMhwzEUY-QkRQKZHPI-HjIghQnvk04yzDjMdUkKAHHg_cbZtVMhfuQ8PLdGtUxc0-1Vylfze12qRrvUtjEhASIAfoHwDCaGuNLE5ZjNLvbtJDN-mxGxe4-33xZP8pwxnuDwbdbv-DfQGPxJ3w</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>Robinson, Delbert G</creator><creator>Schooler, Nina R</creator><creator>Marcy, Patricia</creator><creator>Gibbons, Robert D</creator><creator>Hendricks Brown, C</creator><creator>John, Majnu</creator><creator>Mueser, Kim T</creator><creator>Penn, David L</creator><creator>Rosenheck, Robert A</creator><creator>Addington, Jean</creator><creator>Brunette, Mary F</creator><creator>Correll, Christoph U</creator><creator>Estroff, Sue E</creator><creator>Mayer-Kalos, Piper S</creator><creator>Gottlieb, Jennifer D</creator><creator>Glynn, Shirley M</creator><creator>Lynde, David W</creator><creator>Gingerich, Susan</creator><creator>Pipes, Ronny</creator><creator>Miller, Alexander L</creator><creator>Severe, Joanne B</creator><creator>Kane, John M</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6606-4507</orcidid></search><sort><creationdate>20220901</creationdate><title>Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial</title><author>Robinson, Delbert G ; Schooler, Nina R ; Marcy, Patricia ; Gibbons, Robert D ; Hendricks Brown, C ; John, Majnu ; Mueser, Kim T ; Penn, David L ; Rosenheck, Robert A ; Addington, Jean ; Brunette, Mary F ; Correll, Christoph U ; Estroff, Sue E ; Mayer-Kalos, Piper S ; Gottlieb, Jennifer D ; Glynn, Shirley M ; Lynde, David W ; Gingerich, Susan ; Pipes, Ronny ; Miller, Alexander L ; Severe, Joanne B ; Kane, John M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-46201785a8dddc6b1a486afb198c572004c6ee02a7c21f330db26ba8b18a96c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Diagnostic and Statistical Manual of Mental Disorders</topic><topic>Humans</topic><topic>Psychotic Disorders - diagnosis</topic><topic>Quality of Life</topic><topic>Regular</topic><topic>Schizophrenia - drug therapy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robinson, Delbert G</creatorcontrib><creatorcontrib>Schooler, Nina R</creatorcontrib><creatorcontrib>Marcy, Patricia</creatorcontrib><creatorcontrib>Gibbons, Robert D</creatorcontrib><creatorcontrib>Hendricks Brown, C</creatorcontrib><creatorcontrib>John, Majnu</creatorcontrib><creatorcontrib>Mueser, Kim T</creatorcontrib><creatorcontrib>Penn, David L</creatorcontrib><creatorcontrib>Rosenheck, Robert A</creatorcontrib><creatorcontrib>Addington, Jean</creatorcontrib><creatorcontrib>Brunette, Mary F</creatorcontrib><creatorcontrib>Correll, Christoph U</creatorcontrib><creatorcontrib>Estroff, Sue E</creatorcontrib><creatorcontrib>Mayer-Kalos, Piper S</creatorcontrib><creatorcontrib>Gottlieb, Jennifer D</creatorcontrib><creatorcontrib>Glynn, Shirley M</creatorcontrib><creatorcontrib>Lynde, David W</creatorcontrib><creatorcontrib>Gingerich, Susan</creatorcontrib><creatorcontrib>Pipes, Ronny</creatorcontrib><creatorcontrib>Miller, Alexander L</creatorcontrib><creatorcontrib>Severe, Joanne B</creatorcontrib><creatorcontrib>Kane, John M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Schizophrenia bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robinson, Delbert G</au><au>Schooler, Nina R</au><au>Marcy, Patricia</au><au>Gibbons, Robert D</au><au>Hendricks Brown, C</au><au>John, Majnu</au><au>Mueser, Kim T</au><au>Penn, David L</au><au>Rosenheck, Robert A</au><au>Addington, Jean</au><au>Brunette, Mary F</au><au>Correll, Christoph U</au><au>Estroff, Sue E</au><au>Mayer-Kalos, Piper S</au><au>Gottlieb, Jennifer D</au><au>Glynn, Shirley M</au><au>Lynde, David W</au><au>Gingerich, Susan</au><au>Pipes, Ronny</au><au>Miller, Alexander L</au><au>Severe, Joanne B</au><au>Kane, John M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial</atitle><jtitle>Schizophrenia bulletin</jtitle><addtitle>Schizophr Bull</addtitle><date>2022-09-01</date><risdate>2022</risdate><volume>48</volume><issue>5</issue><spage>1021</spage><epage>1031</epage><pages>1021-1031</pages><issn>0586-7614</issn><eissn>1745-1701</eissn><abstract>Abstract To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization days over 5 years with data from the site-randomized RAISE-ETP trial that compared the EIS NAVIGATE (17 sites; 223 participants) and community care (CC) (17 sites; 181 participants). Inclusion criteria were: age 15–40 years; DSM-IV diagnoses of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, or psychotic disorder not otherwise specified; first psychotic episode; antipsychotic medication taken for ≤6 months. NAVIGATE-randomized participants could receive NAVIGATE from their study entry date until NAVIGATE ended when the last-enrolled NAVIGATE participant completed 2 years of treatment. Assessments occurred every 6 months. 61% of participants had assessments conducted ≥2 years; 31% at 5 years. Median follow-up length was CC 30 months and NAVIGATE 38 months. Primary analyses assumed data were not-missing-at-random (NMAR); sensitivity analyses assumed data were missing-at-random (MAR). MAR analyses found no significant treatment-by-time interactions for QLS or PANSS. NMAR analyses revealed that NAVIGATE was associated with a 13.14 (95%CI:6.92,19.37) unit QLS and 7.73 (95%CI:2.98,12.47) unit PANSS better improvement and 2.53 (95%CI:0.59,4.47) fewer inpatient days than CC (all comparisons significant). QLS and PANSS effect sizes were 0.856 and 0.70. NAVIGATE opportunity length (mean 33.8 (SD = 5.1) months) was not associated (P = .72) with QLS outcome; duration of untreated psychosis did not moderate (P = .32) differential QLS outcome. While conclusions are limited by the low rate of five-year follow-up, the data support long-term benefit of NAVIGATE compared to community care.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>35689478</pmid><doi>10.1093/schbul/sbac053</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6606-4507</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0586-7614
ispartof Schizophrenia bulletin, 2022-09, Vol.48 (5), p.1021-1031
issn 0586-7614
1745-1701
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9434430
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Adolescent
Adult
Antipsychotic Agents - therapeutic use
Diagnostic and Statistical Manual of Mental Disorders
Humans
Psychotic Disorders - diagnosis
Quality of Life
Regular
Schizophrenia - drug therapy
Young Adult
title Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T22%3A08%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20During%20and%20After%20Early%20Intervention%20Services%20for%20First-Episode%20Psychosis:%20Results%20Over%205%20Years%20From%20the%20RAISE-ETP%20Site-Randomized%20Trial&rft.jtitle=Schizophrenia%20bulletin&rft.au=Robinson,%20Delbert%20G&rft.date=2022-09-01&rft.volume=48&rft.issue=5&rft.spage=1021&rft.epage=1031&rft.pages=1021-1031&rft.issn=0586-7614&rft.eissn=1745-1701&rft_id=info:doi/10.1093/schbul/sbac053&rft_dat=%3Coup_pubme%3E10.1093/schbul/sbac053%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35689478&rft_oup_id=10.1093/schbul/sbac053&rfr_iscdi=true